首页> 外国专利> THE DEVELOPMENT OF HUMAN PLACENTA STROMAL CELLS TO PROMOTE DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS AND TEMBRYOID BODIESO TO HEMOPOIETIC STEM CELLS AND THE CULTURE TECHNIQUE FOR DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS AND EMBRYOID BODIES TO HEMOPOIETIC STEM CELLS

THE DEVELOPMENT OF HUMAN PLACENTA STROMAL CELLS TO PROMOTE DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS AND TEMBRYOID BODIESO TO HEMOPOIETIC STEM CELLS AND THE CULTURE TECHNIQUE FOR DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS AND EMBRYOID BODIES TO HEMOPOIETIC STEM CELLS

机译:人胎盘基质细胞促进人胚干细胞和胚性体分化为造血干细胞的发展及人胚干细胞和胚性体分化的培养技术

摘要

The present invention relates to a technique for promoting differentiation into CD34 + 38-human hematopoietic stem cells by complex culture of embryonic bodies prepared from human embryonic stem cells with human placental stromal cells. Specifically, the present invention demonstrates that the embryonic body differentiated from human embryonic stem cells for 5 days in combination with normal human placental stromal cells significantly promotes differentiation into CD34 + 38-human hematopoietic stem cells. Through the differentiation / proliferation of hematopoietic stem cells from human embryonic stem cells, it can be usefully applied for supplying immune cells and producing artificial blood for cell therapy. ; Human placental matrix cell, human embryonic stem cell, human embryoid body, hematopoietic stem cell differentiation
机译:本发明涉及通过由人胚干细胞与人胎盘基质细胞复合培养的胚体来促进向CD34 + 38人造血干细胞分化的技术。具体地,本发明证明了与正常人胎盘基质细胞组合从人胚胎干细胞分化5天的胚胎体显着促进了向CD34 + 38人造血干细胞的分化。通过从人类胚胎干细胞分化/增殖造血干细胞,其可有效地用于提供免疫细胞和生产用于细胞疗法的人造血液。 ;人胎盘基质细胞,人胚胎干细胞,人胚状体,造血干细胞分化

著录项

  • 公开/公告号KR20060016133A

    专利类型

  • 公开/公告日2006-02-21

    原文格式PDF

  • 申请/专利权人 KIM BYUNG SOO;

    申请/专利号KR20060009934

  • 发明设计人 KIM BYUNG SOO;

    申请日2006-02-02

  • 分类号C12N5/08;C12N5;

  • 国家 KR

  • 入库时间 2022-08-21 21:26:30

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号